Open Access

SGLT2 inhibition ‒ early, first-line therapy across the spectrum of HF.

Congress Presentation

About the speaker

Doctor Daniela Tomasoni

Civil Hospital of Brescia, Brescia (Italy)
4 presentations
0 follower

5 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)


Optimizing foundational therapies in HF ‒ can we do better?

Speaker: Professor A. Coats (Coventry, GB)


SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion.

Speaker: Professor G. Rosano (London, GB)


Interactive panel discussion.

Speaker: Professor S. Anker (Berlin, DE) Professor A. Coats (Coventry, GB) Doctor D. Tomasoni (Brescia, IT) Professor G. Rosano (London, GB)



Speaker: Professor C. Lam (Singapore, SG)


Access the full session

SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice

Speakers: Doctor D. Tomasoni, Professor S. Anker, Professor A. Coats, Professor G. Rosano, Professor S. Anker...

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb